Beijing Huakan Biotechnology Co., Ltd.
华龛生物
Beijing Huakan Biotechnology Co., Ltd.
Biotech/Healthcare
Beijing CytoNiche Biotechnology was founded by a research team from Tsinghua University School of Medicine, with Tsinghua University as a shareholder and co-developer. Its core technology was commercialized from Tsinghua research.
Latest round: Series C (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-05-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.